Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnes Y Lee

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancer Treatment Reviews|September 18, 2002
Cancer and thromboembolic disease: pathogenic mechanismsAgnes Y Lee
Critical Care Medicine|January 20, 2010
Malignancy and venous thrombosis in the critical care patientCynthia Wu, Agnes Y Lee
Cancer Investigation|May 30, 2009
Cancer and thrombosis: back to the future renewed interest in an old problemGary H Lyman, Alok A Khorana, Nicole M Kuderer, et al.
Thrombosis and Haemostasis|June 22, 2005
Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patientsMichael J Kovacs, Mark N Levine, Michael Keeney, et al.
Research and Practice in Thrombosis and Haemostasis|December 8, 2021
Cancer-Associated ThrOmboSIs - Patient-Reported OutcoMes With RivarOxaban (COSIMO) - Baseline characteristics and clinical outcomesAnthony Maraveyas, Jan Beyer-Westendorf, Agnes Y Lee, et al.
Thrombosis Research|October 11, 2012
Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized studyLaurie M Elit, Agnes Y Lee, Sameer Parpia, et al.
Thrombosis and Haemostasis|September 3, 2020
Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study)Nils Picker, Agnes Y Lee, Alexander T Cohen, et al.
Annals of Internal Medicine|June 7, 2006
An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trialClive Kearon, Jeffrey S Ginsberg, James Douketis, et al.
The New England Journal of Medicine|June 23, 2015
Screening for Occult Cancer in Unprovoked Venous ThromboembolismMarc Carrier, Alejandro Lazo-Langner, Sudeep Shivakumar, et al.
Annals of Internal Medicine|September 16, 2015
The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness MethodVineet Chopra, Scott A Flanders, Sanjay Saint, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancer Treatment Reviews|September 18, 2002
Cancer and thromboembolic disease: pathogenic mechanismsAgnes Y Lee
Critical Care Medicine|January 20, 2010
Malignancy and venous thrombosis in the critical care patientCynthia Wu, Agnes Y Lee
Cancer Investigation|May 30, 2009
Cancer and thrombosis: back to the future renewed interest in an old problemGary H Lyman, Alok A Khorana, Nicole M Kuderer, et al.
Thrombosis and Haemostasis|June 22, 2005
Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patientsMichael J Kovacs, Mark N Levine, Michael Keeney, et al.
Research and Practice in Thrombosis and Haemostasis|December 8, 2021
Cancer-Associated ThrOmboSIs - Patient-Reported OutcoMes With RivarOxaban (COSIMO) - Baseline characteristics and clinical outcomesAnthony Maraveyas, Jan Beyer-Westendorf, Agnes Y Lee, et al.
Thrombosis Research|October 11, 2012
Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized studyLaurie M Elit, Agnes Y Lee, Sameer Parpia, et al.
Thrombosis and Haemostasis|September 3, 2020
Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study)Nils Picker, Agnes Y Lee, Alexander T Cohen, et al.
Annals of Internal Medicine|June 7, 2006
An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trialClive Kearon, Jeffrey S Ginsberg, James Douketis, et al.
The New England Journal of Medicine|June 23, 2015
Screening for Occult Cancer in Unprovoked Venous ThromboembolismMarc Carrier, Alejandro Lazo-Langner, Sudeep Shivakumar, et al.
Annals of Internal Medicine|September 16, 2015
The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness MethodVineet Chopra, Scott A Flanders, Sanjay Saint, et al.
Pageof 2